{
  "abstract": "Infective endocarditis (IE) is a complex and severe disease with in-hospital mortality plateauing at ∼20% and 1 year mortality up to 40% in most contemporary cohorts. Although 60–70% of patients with IE present theoretical indication(s) for surgery,1 cohort studies report lower rate of cardiac surgery during the acute phase of IE (20–50%), with striking heterogeneity. This medical decision is particularly complex, ideally taken by the endocarditis team, primarily based on the synergistic expertise of cardiologists, infectious diseases physicians, cardiac surgeons, anaesthesiologists and intensivists. Indeed, the strategy that will be finally selected, in agreement with the patient and/or his relatives, may be a major determinant of whether the patient will die or survive, with or without impaired quality of life.",
  "authors": [
    {
      "affiliations": [
        "Pontchaillou University Hospital, Rennes, France"
      ],
      "name": "Pierre Tattevin"
    },
    {
      "affiliations": [
        "Rennes University Hospital, Rennes, France"
      ],
      "name": "David Luque Paz"
    }
  ],
  "title": "Staphylococcus aureus is not a stand-alone indication for cardiac surgery in patients with infective endocarditis",
  "uid": "47a2e6c9-4920-5b3d-b278-b60e2898f6fd"
}